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Neuroblastoma (NB) is one of the most common malignant
diseases of childhood. The most frequent genetic abnormality
reported to date is the deletion of the short arm of chromosome 1
(Brodeur et al, 1981; Gilbert et al, 1984). Recent investigations
have reported that the frequency of loss of heterozygosity (LOH) in
1p ranged from 20 to 89% (Fong et al, 1989, 1992; Suzuki et al,
1989; Weith et al, 1989; Takayama et al, 1992; Caron et al, 1993,
1996; Schleiermacher et al, 1994; Takeda et al, 1994; Martinsson et
al, 1995), and two or more tumour suppressor genes have been
thought to be located in chromosome 1p (Schleiermacher et al,
1994; Takeda et al, 1994; Caron et al, 1995; Cheng et al, 1995).
However, the genes on chromosome 1 responsible for NB have not
yet been reported. On the other hand, allelic loss in the long arm of
chromosome 14 (Suzuki et al, 1989; Fong et al, 1992; Takayama et
al, 1992; Srivatsan et al, 1993; Caron et al, 1996) has also been
frequently reported, and these investigations have suggested that a
tumour suppressor gene(s) might be located in chromosome bands
14q32-qter (Suzuki et al, 1989; Fong et al, 1992; Takayama et al,
1992). Furthermore, in chromosome arm 14q, commonly deleted
regions have also been reported in several other malignancies,
including renal cell carcinoma (Kovacs and Frisch, 1989),
colorectal carcinoma (Sasaki et al, 1989; Young et al, 1993) and
ovarian carcinoma (Bandera et al, 1997). These deleted regions are
likely to overlap with that in NB; there may be some common path-
ways or genes associated with the tumorigenesis of these tumours.
As the first step towards the isolation and characterization of the
tumour-associated gene responsible for initiation and/or progres-
sion of NB, we analysed 54 paired samples of tumour and normal
tissues from patients with NB for LOH analyses at 12 microsatellite
loci. Herein we report the localization of a putative tumour
suppressor gene to a 1.1-Mb region on 14q32.
MATERIALS AND METHODS
Patients with NB analysed
The Ethical Committee of Tohoku University School of Medicine
approved all protocols and samples used in the present study. A
total of 54 patients with NB were analysed. Mass screening was
performed for 52 of 54 patients, and 36 (69%) were positive.
Clinical characteristics of the tumours are summarized in Table 1.
The ages of the patients at the time of operation ranged from 6
months to 8 years. They were staged according to Evans’ classifi-
cation (Evans et al, 1971). Primary sites of NB were as follows: 37
from adrenal gland, 12 from retro-peritoneum and five from medi-
astinum. Six patients had been treated with chemotherapy before
operation. None had been treated with radiotherapy.
Tissue samples
Tumour and corresponding normal tissues were obtained from NB
patients treated at the Tohoku University Hospital (Sendai, Japan),
Saitama Cancer Center Hospital (Saitama, Japan), and their related
institutions within the period from September 1988 to June 1995.
Tumour samples were frozen in liquid nitrogen immediately after
resection and stored at –80°C until use. In each case, corresponding
normal tissue was obtained from one of the following: peripheral
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of the liver, or non-metastatic lymph node. Some of the samples
were obtained from formalin-fixed and paraffin-embedded tissues.
Analysis of LOH
To obtain the genomic DNAs for microsatellite analysis, we
performed micro dissection; tissue samples embedded in paraffin
blocks were cut into 50-mm-thick slices and deparaffinized
with xylene. The genomic DNAs were extracted as previously
described (Kimura et al, 1996). DNAs from fresh frozen tumour
tissues and peripheral blood cells were also extracted as previously
described (Sambrook et al, 1989; Sato et al, 1990). Based on the
Généthon human linkage map (Dib et al, 1996), nucleotide
sequences of primer sets for microsatellite markers on chromo-
some band 14q32 were designed to amplify less than or around
100-bp so that we could perform polymerase chain reaction (PCR)
amplification from the DNA prepared from paraffin sections.
Nucleotide sequences and annealing temperatures of these primers
are summarized in Table 2. In each primer set, the primer corre-
sponding to the DNA strand harbouring the CA dinucleotide
repeat was labelled with [g-32P] ATP, and PCR amplification was
performed as described previously (Kimura et al, 1996). We
performed electrophoreses of the PCR products in 6% polyacrl-
amide/8 M urea/32% formamide denatured gels, obtained auto-
radiograms, and analysed them densitometrically. When a sample
exhibited some heterozygosity, allelic imbalance, probably loss,
was assigned if the intensity of one of the bands in the tumour
sample showed more than a 50% reduction from that of the corre-
sponding normal tissue. At least two independent experiments as
well as experiments with the labelled antisense primer (corre-
sponding to the strand for the GT dinucleotide repeat) were
performed to confirm our results. Fluorescence in situ hybridiza-
tion (FISH) analysis was also performed in the critical cases to
confirm our microsatellite analysis (see below).
Isolation of the genomic clones harbouring the
commonly deleted region
A yeast artificial chromosome (YAC) clone y964D10 harbour-
ing microsatellite marker D14S62 that had been isolated by
PCR-based screening was purchased from Research Genetics
(Huntsville, AL, USA). A cosmid library was constructed using
the total yeast DNA of this YAC clone by methods described
previously (Ariyama et al, 1995), and a clone named c14–16
harbouring D14S62 was isolated by colony hybridization. This
clone was used for FISH analysis (see below). BAC clones were
obtained by screening two total human BAC libraries; one was
constructed by Asakawa et al (1997), and the other was purchased
from Research Genetics (Huntsville, AL, USA). From the latter,
we prepared a PCR-based BAC screening system and isolated
BAC clones. The BAC DNAs were extracted by automated DNA
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Table 1 Summary of samples analysed
Number of patientsa MYCN Chromosome ploidy
Stage Youngerf Olderg Total – + bAP cDP dND
I 9 (2) 1 (0) 10 (2) 9 0 8 1 1
II 14 (4) 4 (4) 18 (8) 18 0 12 2 4
III 5 (1) 4 (0) 9 (1) 9 0 6 0 3
IV 2 (0) 13 (5) 15 (5) 7 6 5 3 7
IVs 2 (1) 0 (0) 2 (1) 2 0 2 0 0
Total 32 (8) 22 (9) 54 (17) 45 6 33 6 15
aNumber of patients who showed loss of heterozygosity on chromosome arm 14q are indicated in brackets. bAP: aneuploid, cDP: diploid, dND:
unable to examine. eAmplification of MYCN was not determined in three patients. fYounger: younger than 12 months of age at operation.
gOlder: older than 12 months of age at operation.
Table 2 Nucleotide sequences of the primers for each microsatellite marker
Locus Annealing
Nucleotide sequence
symbol temperature CA strand GT strand
D14S990 55°C AGCCACATGCATCCTCTGTC GAATAAAGTTGCACTGTGACTG
D14S63 55°C CTCTAACACTCACCATGTTCAT CTGCCAGAGAGCCACACTG
D14S81 55°C ACTTATCCTAAAATGAAACTNCA CAGAGCAGGACCCTTTCTCA
D14S265 55°C GTTTTTGGCTATTATGAATATGG CATACATATGCATGCACTCTG
D14S62 55°C GAGGCTTCAGCCTTGCTGT TCTGTGTGTGATGTATCTGCT
D14S987 55°C CTTGAGGCCAGGAGTTTGAG AGCTGAACTATTTTAATTCAATTGT
D14S979 55°C TGTACCACCACCTCCTTATAC GATGCTCAATGAACAGCCTGA
D14S65 55°C CCCTAAAGATCCCTGCCATC CTGTTCAAATCAGGACCA
D14S998 55°C CATCCAAGGGAAAATGAGAG TTCTCAGATAAATGACAGCGT
D14S267 55°C GTTCTTTAAGAGCCAAACATAC GGATTATTTTNCAAGGTTTCGTA
D14S250 55°C TGATGCAGCAATCACTGGAC ACCCCTGCATTGTTTGAG
D14S260 55°C TTTGAAAATGTAAAAGTGTTATTCC AAAACGGTCACTATGTTTTCCA
Markers are ordered from the centromeric end to the telomeric one on chromosome band 14q32.Deletion mapping of 14q32 in human neuroblastoma 1803
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Figure 1 (A) LOH study employing microsatellite markers on chromosome band 14q32. Intensities of bands of DNA from tumours indicated by arrows are
significantly reduced when compared with those of corresponding normal tissues. Cut-off value of allelic loss applied in this study was more than 50% reduction.
In case 38, the intensities of the upper bands indicated by arrows were reduced by 65% and 60% at D14S979 and D14S65 respectively. In case 69, the
intensities of the bands indicated by arrows were reduced by 58% and 56% from the corresponding normal bands at D14S265 and D14S62 respectively. T,
tumour samples; N, normal tissue samples; H, homozygous; L, loss of heterozygosity; R, retention. (B) Summary of 17 neuroblastoma patients who showed
allelic losses on chromosome band 14q32. A closed bar on the right side indicates the commonly deleted region. Open circle, retained heterozygosity; closed
circle, loss of heterozygosity; H, constitutionally homozygous; –, not determined. Origins of the tumour are indicated at the bottom; A, adrenal gland; R, retro-
peritoneum; M, mediastinum
A
Bextract system PI-100 (Kurabo, Neyagawa, Japan), and the DNAs
were used for FISH analyses and the contig construction of the
commonly deleted region.
Analysis of FISH
To confirm the results of the microsatellite analysis, we performed
dual-colour FISH according to the methods described previously
(Nagase et al, 1997). The clones were labelled with either biotin-
16-dUTP or digoxigenin-11-dUTP for FISH probes, and the
samples from critical cases were hybridized with these labelled
probes for at least 2 days at 37°C. Then, to obtain fluorescence
signals, they were hybridized with anti-avidin–FITC (fluoroscein
isothiocyanate) and anti-digoxigenin–rhodamine, counterstained
with DAPI to obtain the FISH images. These images were then
incorporated with LEICA DMRXA microscope with COHU CCD
black and white camera 4910 and analysed by LEICA QFISH soft-
ware and Q550CW hardware package (LEICA, Heerbrugg,
Switzerland). In the FISH analysis, we analysed allelic losses or
imbalances by counting the number of FISH signals in more than
50 nuclei. To confirm the results of FISH, we changed the
labelling of the probe in each labelled clone and performed inde-
pendent experiments with each probe.
Construction of the BAC contig
We constructed a sequence-ready BAC contig between D14S62
and D14S267, approximately 8-cM region. First we selected BAC
clones corresponding to the microsatellite markers between
D14S62 and D14S267, including D14S62 and D14S267, using the
PCR-based screening system coupled with colony hybridization.
Then we determined the nucleotide sequences of both ends of each
isolated BAC clone, designed the primer sets for PCR, and
performed screening to select the flanking BAC clones. To
confirm this sequence-ready BAC contig, we performed Southern
hybridization of all the BAC clones with the PCR primers.
Consequently we obtained a BAC contig covering the region
between D14S62 and D14S267, including the commonly deleted
region, as shown in Figure 3. To measure the insert sizes of the six
BACs covering the commonly deleted region, we performed NotI
digestion of DNA prepared in agarose plugs followed by pulsed-
field gel electrophoresis (PFGE). Southern blot hybridizations
were done with total human DNA labelled with [a-32P] dCTP to
measure the insert sizes of the BAC clones.
Analysis of MYCN amplification
DNAs extracted from tumour samples were analysed by slot blot
hybridization according to the methods described by Kafatos et al
(1997). Hybridization was performed using MYCN cDNA as the
probe, and the ratio of the signal intensity of each tumour sample to
the corresponding normal one was measured densitometrically. We
evaluated the tumour specimens as MYCN amplification-positive if
the tumour showed at least twice the intensity of the normal tissue.
Analysis of chromosomal ploidy
Chromosomal ploidy of tumour cells was analysed using the G-
banding method or flowcytometry. There were 15 patients whose
tumour cells showed no division in culture within 24 h; thus we
examined 39 informative cases for analysis of chromosomal
ploidy.
RESULTS
Initially, we investigated the clinicopathological features of 54 NB
cases in this study. We first investigated the MYCN amplification.
All but three patients, cases 3, 20 and 22, were examined; amplifi-
cation of MYCN was detected only in six, all of whom were stage
IV. We also examined the chromosomal ploidy of the tumour cells;
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Figure 2 Dual-colour FISH image of Case 69. Three red signals for b726B5 at D14S987 were observed in this image, whereas only two or fewer green
signals for c14–16 at D14S62 were observed in each interphase spread. The counts of FISH signals in case 69 are shown by coloured dots in the right side. In
most of the nuclei, the number of signals for D14S987 is greater than that for D14S62, confirming the results of microsatellite analyses33 (85%) of 39 informative cases were aneuploid. These data are
summarized in Table 1. We could not detect any significant corre-
lations between age of onset, chromosomal ploidy and amplifica-
tion of MYCN. There were significant correlations between the
stage classification (early stages: stage I, II, and IVs; late stages:
stage III and IV except for IVs) and age of onset or chromosomal
ploidy or amplification of MYCN (P = 0.00008, P = 0.04 and
P = 0.00006 respectively). Since 69% of our cases were selected
by mass screening, the above mentioned correlation may have
been influenced.
We then analysed allelic imbalances of chromosome band
14q32 in the 54 cases. We first analysed seven microsatellite loci
(D14S81, D14S265, D14S62, D14S65, D14S267, D14S250 and
D14S260) by a microsatellite-based PCR-LOH method and then
added five more microsatellite loci (D14S990, D14S63, D14S987,
D14S979 and D14S998) for a total of 12 loci on chromosome arm
14q. Seventeen (31%) of 54 patients showed allelic imbalances,
probably LOHs, at one or more loci on 14q. None of the six
patients who had been treated with chemotherapy before their
operations showed allelic imbalances. In 15 (88%) of the 17
patients that showed allelic imbalances, such imbalances,
predicted to be LOHs, were observed at almost all informative
loci; deletion of large segment of chromosome arm 14q including
14q32 was suggested in these patients. On the other hand, cases 38
and 69 had more specific patterns of loss. In case 38, the LOHs
were observed at the D14S979 and D14S65 loci; the intensities of
the upper bands were reduced by 65% and 60% respectively, from
those of the corresponding normal bands. In this patient, hetero-
zygosity was retained at two flanking markers D14S62 and
D14S998. In case 69, the intensity of the bands indicated by
arrows was reduced by 58% and 56% from the corresponding
normal bands at D14S265 and D14S62 loci respectively.
Heterozygosity was retained at the D14S987 and D14S65 loci in
Deletion mapping of 14q32 in human neuroblastoma 1805
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Table 3 Summary of cases showing 14q LOH
Case Age Stage N-myc gene Ploidy Mass
no. amplification screening
3 10 months I ND AP MS
5 8 months II – AP MS
6 1 year 1 month II – AP MS
9 1 year 10 months II – AP MS
10 2 years II – AP FL
12 8 months II – AP MS
14 6 months II – ND MS
17 1 year III – AP FL
20 4 year IVA ND ND FL
22 1 year 1 month IVA ND AP FL
26 1 year 11 months II – ND MS
35 6 months IVs – AP MS
38 3 years IVA – DP FL
40 6 years IVA + ND FL
49 8 months I – AP MS
54 1 year 5 months IVB – AP FL
69 8 months II – AP MS
AP, aneuploid; DP, diploid; ND, not examined. MS, picked up by mass
screening; FL, failed to pick up by mass screening.
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Figure 3 A sequence-ready BAC contig covering the deleted region. Based on this contig, the commonly deleted region was covered with six overlapping
BAC clones, and the physical distance was approximately 1.1 Mb. The centromeric portion is on the upper layer, and telomeric portion is on the bottom layer.
The clone b228J15, indicated by an asterisk, bridges the two clones, b466M2 (in the upper layer) and b30K16 (in the bottom layer). The cosmid clone c14–16
that was isolated initially is also shown. Sizes of the BAC clones covering the commonly deleted region are also provided in the parenthesisthis tumour. Thus these two cases showed interstitial deletions on
chromosome band 14q32; according to the results, the smallest
region of common allelic loss was defined between D14S62 and
D14S987. The results of the microsatellite analysis are indicated in
Figure 1. None of the tumours showed microsatellite instability
(MSI) at any of the tested microsatellite loci.
To confirm the microsatellite analysis on chromosome band
14q32, dual-colour FISH analysis was performed in case 69. We
could not sufficiently analyse case 38, because the tumour speci-
men was not for FISH analysis. Typical results are shown in Figure
2. A majority of the nuclei showed three signals for b726B5, a
BAC clone harbouring microsatellite marker D14S987 (rhodamine,
red), but only two signals for c14–16, a cosmid clone harbouring
D14S62 (FITC, green). Signal numbers that were counted in more
than 50 nuclei are shown by dots on the right side of Figure 2. This
result indicates a decrease in copy number at D14S62 from that at
D14S987. These results were consistent with those of microsatel-
lite analyses in case 69. We further performed FISH analyses with
marker sets, D14S65 and D14S998, D14S990 and D14S62, and
D14S990 and D14S998; the results showed signal count reductions
at D14S65 and D14S62 with no reduction but rather triploidy at
both D14S990 and D14S998 respectively (data not shown). These
results supported our results of PCR-LOH analysis; case 69
appeared to harbour an interstitial deletion between D14S81 and
D14S62. Tumours with LOHs on 14q are summarized in Table 3;
case 38 was diploid, and case 69 was aneuploid.
To investigate further, we constructed a BAC contig spanning an
8-cM region including the commonly deleted region, as shown in
Figure 3. The relative order of the microsatellite markers that were
not determined precisely in the linkage map was found to be as
follows: 14cen-D14S62-D14S987-D14S1067-D14S979-D14S65-
D14S998-D14S1019-D14S267-14qter. The region between D14S62
and D14S267, approximately 8-cM according to the linkage map,
was covered with 32 clones of minimum tiling path, and the
commonly deleted region was covered with a minimum tiling path
consisting of six overlapping BAC clones. PFGE with NotI digested
BAC DNA was performed to measure the physical distance of
the commonly deleted region; it was estimated to be approximately
1.1-Mb.
DISCUSSION
In the present study, 31% allelic loss was observed on chromosome
arm 14q, in good agreement with other reports on the LOH analysis
of 14q (Suzuki et al, 1989; Fong et al, 1992; Takayama et al, 1992).
The centromeric and telomeric borders of the commonly deleted
region were D14S62 and D14S987; the interval was 1-cM
according to the Généthon human linkage map (Dib et al, 1996). We
established that the physical size of this region is approximately 1.1-
Mb by PFGE. This region overlaps that of the previous work
(14q32-qter) by Takayama et al (1992), which was done using
restriction fragment length polymorphism (RFLP) markers. Another
report on NB (Theobald et al, 1999) suggests the presence of two or
more loci for putative tumour suppressor genes on chromosome 14
by RFLP and microsatellite analysis; one of them is between
markers D14S1 and D14S16 and the other one is between markers
D14S17 and D14S23 in 14q32. However, those areas are large; our
study may be a first report of fine deletion mapping of 14q32 in NB.
Recently, disruption of the DNA mismatch repair system has
been found to important associations with carcinogenesis of various
human cancers and to involve microsatellite instability (MSI). No
MSI was observed in this study, in good agreement with those in
previous reports (Schleiermacher et al, 1994; White et al, 1995).
MSI is thus not generally involved in the tumorigenesis in NB.
In NB, 1p deletion and 17q amplification are associated with the
age of onset and/or the clinical stage of NB, or with chromosomal
ploidy (Fong et al, 1989; Takeda et al, 1994; Bown et al, 1999).
Amplification of MYCN and 17q was associated with poor prog-
nosis (Brodeur et al, 1992; Bown et al, 1999) as was a relatively
large deletion of chromosome 1p (Schleiermacher et al, 1994;
Takeda et al, 1994; Caron et al, 1995). Thus genetic alterations in
NB appear to be associated with some clinical features. In this
study, however, there was no correlation between LOHs on 14q32
and any clinical feature, including stage, chromosomal ploidy,
MYCN amplification and age of onset (P = 0.38, P = 0.31, P = 0.45
and P = 0.19 respectively, by Fisher’s exact test). In the present
study, 36 cases were picked up by mass screening of 52 patients;
the efficiency was 69% (36/52). More than 80% of the patients
examined showed aneuploidy. Although we cannot exclude the
possibility of a sampling bias, there is also no correlation between
the mass screening and 14q32 LOH (P = 0.83). It is interesting that
the LOH on 14q in this study showed the same frequency as
reported previously despite the possible sampling bias.
In this study, we further performed FISH analysis to confirm the
microsatellite analysis. By FISH analysis, we could detect an
interstitial allelic deletion in case 69 that was consistent with the
microsatellite analysis. In the LOH analysis of this study, we
cannot exclude the possibility of ‘pseudo’ allelic loss derived from
aneuploidy, but the FISH analysis clearly demonstrated an allelic
imbalance, so we could confirm that the LOHs by microsatellite
analysis were caused by true allelic losses in 14q32.
In this study, we further constructed a sequence-ready BAC
contig in the region spanning D14S62 through D14S267. A
minimum tiling path consisting of 32 overlapping BAC clones
covered the entire region. The smallest region of common allelic
loss in NB identified in the present study was approximately 1.1-
Mb. Further investigations are necessary to understand and char-
acterize the role of a putative tumour suppressor gene in 14q32 in
the pathogenesis of NB. Moreover, the contig presented in this
study will be a great help in cloning and characterizing the gene(s)
that is closely associated with pathogenesis of tumours of the
colorectum, ovary, and kidney as well as NB.
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